These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 26717345)

  • 1. A misleading diagnosis in acute coronary syndrome: tirofiban-induced alveolar hemorrhage.
    Şarlı B; Uğurlu M; Tok A; Dondurmacı E; Sağ Ertürk F
    Turk Kardiyol Dern Ars; 2015 Dec; 43(8):753. PubMed ID: 26717345
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety of tirofiban therapy in very old patients with acute coronary syndrome or non-Q-wave myocardial infarction.
    Graf C; Nkoulou R; Trombert V; Perrenoud JJ
    J Am Geriatr Soc; 2005 Jan; 53(1):172-3. PubMed ID: 15667404
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic efficiency of tirofiban in acute coronary syndromes.
    Burnett JR; Blennerhassett J; McConnell W; O'Leary PC; Vasikaran SD
    Lancet; 2000 Mar; 355(9207):929-31. PubMed ID: 10752729
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of intracoronary versus intravenous administration of tirofiban in primary percutaneous coronary intervention.
    Erdim R; Erciyes D; Görmez S; Karabay KO; Catakoğlu AB; Aytekin V; Demiroğlu C; Gülbaran M
    Anadolu Kardiyol Derg; 2010 Aug; 10(4):340-5. PubMed ID: 20693130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alveolar hemorrhage following tirofiban treatment. A misleading diagnosis.
    Agnelli D; Al-Kayyali S
    Rev Esp Cardiol; 2010 Mar; 63(3):368-9. PubMed ID: 20197002
    [No Abstract]   [Full Text] [Related]  

  • 6. Antithrombotic treatment after an acute coronary syndrome.
    Prescrire Int; 2014 Oct; 23(153):231. PubMed ID: 25964963
    [No Abstract]   [Full Text] [Related]  

  • 7. Between a rock and a hard place: weighing thrombotic risk against bleeding complications.
    Hudzik B; Polonski L
    Am J Cardiol; 2013 May; 111(9):1375. PubMed ID: 23622104
    [No Abstract]   [Full Text] [Related]  

  • 8. The score is in but is the decision final?
    Brinker J
    J Am Coll Cardiol; 2010 Jun; 55(23):2567-9. PubMed ID: 20513596
    [No Abstract]   [Full Text] [Related]  

  • 9. Incidence, outcomes, and management of bleeding in non-ST-elevation acute coronary syndromes.
    Gutierrez A; Rao SV
    Cleve Clin J Med; 2010 Jun; 77(6):369-79. PubMed ID: 20516248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tirofiban induced anemia without thrombocytopenia.
    Ede H; Erkoç MF; Alüzüm H; Özdemir ZT; Erbay AR
    Int J Cardiol; 2015 Jan; 179():500-1. PubMed ID: 25465817
    [No Abstract]   [Full Text] [Related]  

  • 11. Routine early versus deferred provisional tirofiban treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Zhang Y; Gao C; Liu H; Wang X; Yang H; Li M; Wang X; Zhu Z; Hu D
    Clin Exp Pharmacol Physiol; 2013 Apr; 40(4):289-94. PubMed ID: 23551127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of upstream tirofiban versus downstream tirofiban on myocardial damage and 180-day clinical outcomes in high-risk acute coronary syndromes patients undergoing percutaneous coronary interventions.
    Liu T; Xie Y; Zhou YJ; Li YP; Ma HY; Guo YH; Liu YY; Zhao YX; Shi DM
    Chin Med J (Engl); 2009 Aug; 122(15):1732-7. PubMed ID: 19781316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tirofiban-induced acute profound thrombocytopenia after primary angioplasty.
    Dursunoglu D; Taskoylu O; Gür S; Sari I
    Asian Cardiovasc Thorac Ann; 2013 Feb; 21(1):74-6. PubMed ID: 23430426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute profound thrombocytopenia after treatment with tirofiban and off-pump coronary artery bypass grafting.
    Beiras-Fernandez A; Kowert A; Jiru P; Weis M; Spannagl M; Reichart B; Schmoeckel M
    Ann Thorac Surg; 2009 Feb; 87(2):629-31. PubMed ID: 19161801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffused alveolar hemorrhage: A rare and severe complication of tirofiban-induced thrombocytopenia.
    Zhou X; Peng H; Yin Y; Huang H; Zeng J; Ouyang F
    Int J Cardiol; 2016 Mar; 206():93-4. PubMed ID: 26785031
    [No Abstract]   [Full Text] [Related]  

  • 16. [Last generation anti-thrombotic drugs and cerebral hemorrhage ].
    Fontana P
    Rev Med Suisse; 2015 Jan; 11(459):255. PubMed ID: 25845165
    [No Abstract]   [Full Text] [Related]  

  • 17. Tirofiban for cocaine-induced coronary artery thrombosis: a novel therapeutic approach.
    Frangogiannis NG; Farmer JA; Lakkis NM
    Circulation; 1999 Nov; 100(18):1939. PubMed ID: 10545440
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bleeding risk related to combined aspirin and other antithrombotic drug use in patients with acute coronary syndrome: prevention and therapy strategies].
    Li XY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Dec; 38(12):1057-9. PubMed ID: 21215136
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety evaluation of tirofiban.
    Valgimigli M; Tebaldi M
    Expert Opin Drug Saf; 2010 Sep; 9(5):801-19. PubMed ID: 20670206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs of bleeds relating to acute coronary syndrome therapies.
    Bufe A; Emile F; Drogoul L; Guindo Soldevila J; Giuseppe DP; Maddalena L; Janzon M; Brown RE
    J Med Econ; 2010; 13(2):236-40. PubMed ID: 20465368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.